Four novel platelet activating factor (PAF) antagonists, Sch 47918, Sch 49026, Sch 49027 and Sch 49028, were isolated from the fermentation broth of the fungal culture, Phomasp. (ATCC 74077). The structures of these compoundswere elucidated by spectroscopic methods. The structure and stereochemistry of the first isolated component, Sch 47918, were confirmed by single crystal X-ray diffraction analysis. Sch 49028, the most active component, was found to inhibit PAF-induced human platelet aggregation in vitro with an IC50 of 1.26 /zm. However, this compound was inactive in vivo at 5 mg/kg, iv against PAF-induced bronchospasm in guinea pigs.
PAF-induced human platelet aggregation in vitro with an IC50 of 1.26 /zm. However, this compound was inactive in vivo at 5 mg/kg, iv against PAF-induced bronchospasm in guinea pigs.
Platelet activating factor (PAF, l-O-alkyl-2-(i?)-(acetylglyceryl)-3-phosphocholine)
is a potential mediator of allergic1 '2) and non-allergic inflammatory3) diseases. PAF binds to specific receptors on various cell types leading to diverse biological responses including platelet aggregation, leukocyte activation and hypotension. 40 The PAF receptor is a very attractive target for developing a new type of anti-allergic and anti-inflammatory drug. In recent years, the search for PAF antagonists has led to the discovery of a number of new natural products from microbial origin.5~8) However, a majority of these compounds possesses the dialkylthiopiperazinedione moiety.9) In the course of our screening program for novel PAF inhibitors, four macrocyclic compounds were discovered from the fermentation broth of a fungal culture. These compoundsrepresent an uncommon 14-memberedmacrocyclic ring system with a bridged 6-memberedring. In this report, we describe the details of the identification and fermentation of the producting culture, the isolation, physico-chemical properties, structure elucidation and biological activities of the pure compounds.
Experiment al Taxonomy
Agar plugs, 2 x 2mm, from 10 to 14-day old malt extract agar slants, incubated at 22°C, were used as the inoculum for morphological and cultural characteristics. Morphological characteristics were observed on plates of malt extract agar10) incubated at 22°C for 10 to 12 days. Culture characteristics were observed on petri dishes containing malt extract, malt yeast, potato dextrose and Czapek's Dox agars10) after 12 days at 22°C in the dark.
Fermentation
The initial stage inoculum for the fermentation of the PAFantagonists was prepared by transferring 2.5ml of a frozen whole broth (at -20°C) to 50ml of germination medium in 250ml Erlenmeyer flasks. The germination medium (g/liter) consisted of Proteose peptone #3, 0.5%; sodium chloride, 0.5%; glucose, 2%; yeast extract, 0.3%; soy grits, 0.5%; and sodium potassium phosphate (monobasic) 0.5%. The pH of the mediumwas adjusted to 7.0 prior to sterilization. The flasks were incubated at 30°C on a gyratory shaker at 300 rpm for 48 hours. For the second stage germination, a 2-liter Erlenmeyer flask containing 350ml of the same medium was inoculated with 25ml of the first stage germination and incubated as described above for 72 hours. Ten-liter fermentations were carried out in 14-liter fermentors (New Brunswick Scientific, Edison, N.J.) in a medium containing Neopeptone, 1 %; and glucose, 4%. The pH of the medium was adjusted to 7.0 before sterilization.
The second stage inoculum (3.5%) was used to initiate the fermentation which was conducted at 30°C with 4.5 liters/minute air flow and 400 rpm agitation for five days. An antifoam agent such as SAG(Union Carbide Corp., 50% solution) was added, if necessary, to the fermentors to control foam. During the course of the fermentation, production of the PAF-active complex in the whole broth was monitored using the PAF-induced platelet aggregation assay.
Isolation
The fermentation broth (20 liters) was extracted with ethyl acetate (80 liters) at harvest pH (see Scheme   1 ). The extract was evaporated in vacuo to a brown syrup. The syrup was dissolved in a minimumamount of dichloromethane -methanol (7 : 3) solvent mixture and loaded onto a Sephadex LH-20 column (700 ml). 
Spectroscopy
The melting points were measured on a MEL-TEMP apparatus (Laboratory Devices, Cambridge, MA)and are uncorrected. The optical rotations were measured on a Rudolph Research model 'AUTOPOL IIP automatic polarimeter. IR spectra were obtained using a Nicolet FTIR model 10-MXinstrument. UV spectra were recorded on a Hewlett Packard '8450 A' UV-vis spectrophotometer. CI and FAB-massspectra were produced on a Hewlett Packard '5989 A' mass spectrometer using particle beam interface in methanol, and a Finnigan MAT-312 mass spectrometer in a glycerol-thioglycerol matrix, respectively. High resolution EI-MS were recorded on a Finnigan MAT-90instrument using perfluoroalkene-225 (PFK) as a reference. Both *H and 13C NMRspectra were obtained from Varian XL-300 instrument operating at 300 and 75 MHz,respectively.
In Vitro PAF Assay Preparation of platelet-rich plasma (PRP): Human blood (50 ml) was collected from healthy donors. The blood (50ml) was mixed with an anticoagulant solution (5 ml) containing sodium citrate (3.8%) and glucose (2%). Blood was centrifuged at 200 x g for 20 minutes and the supernatant PRPwas carefully transferred into a polypropylene tube. Platelet-poor plasma (PPP) was prepared by centrifuging PRP at 800 xg for 15 minutes. PRP was used within 3 hours of drawing the blood.
Platelet aggregation assay: Platelet aggregation can be induced by addition of various platelet agonists, including PAFor thrombin, to PRP. Aggregation can be quantitated by measuring light transmission through PRPand comparing it to transmission through PPP. The aggregation assays were performed using a dual-channel aggregometer (Model 440, Chrono-Log Corp., Havertown, PA). PRP (0.45 ml) in aggregometer cuvettes was continually stirred (37°C). Solution of test compoundsin DMSO or vehicle alone (final concentration of DMSO=0.1%,v/v) were added to the PRP, followed by addition of PAF solutions to achieve a final concentration of l~5 x lO~8 M. Incubations were continued until the increase in light transmission reached a maximum(usually about 2 minutes). Values for inhibition were calculated by comparing maximal aggregation obtained in the absence and the presence of the compound. The IC50 was the concentration of compoundat which 50%inhibition of aggregation occurred.
In Vivo PAF Assay PAF-induced bronchospasm in guinea pigs: Male Hartley guinea pigs (450~550 g) were obtained from Charles River Breeding Laboratories (Wilmington, MA). The animals were fasted overnight and were anesthetized in the morning with 0.9 ml/kg of dialurethane ip (containing 0. 1 g/ml of diallylbarbituric acid, 0.4g/ml of ethylurea and 0.4g/ml of urethane). The left jugular vein was cannulated for the administration of compounds.The trachea was cannulated and the animals were ventilated by rodent respirator at 55 strokes/minute with a stroke volume of 4ml. A side arm to the tracheal cannula was connected to a pressure transducer to obtain a continuous measure of inflation pressure. Bronchoconstriction was measured as the percentage of increase in inflation pressure that peaked within 2 minutes after challenge with PAF. The animals were challenged iv with PAF(OAfig/kg in isotonic saline containing 0.25% BSA). Each animal was challenged only once. The dose of PAFwas selected from preliminary dose-response studies to increase inflation pressure 300~400% (40-50cm H2O) or 70 to 80% of the maximumresponse to PAF. The effect of a compoundon the bronchospasm is expressed as percentage of inhibition of the increase in inflation pressure compared to the increase in a corresponding control group. On malt extract agar colonies grew to 33mmin diameter and appeared humpedin the center and velutinous. Hyaline aerial mycelia were formed along with blackish brown submerged mycelia. Pycnidia were absent from margins but were numerousand large in other regions of the colony.
On malt yeast agar colonies grew to 42mmin diameter, were low spreading, and velutinous in older regions. Aerial mycelia were hyaline, lanose and in sectors, with blackish brown submerged mycelia in older regions and sectors. Pycnidia were abundant.
Colonies on potato dextrose agar reached 44mmin diameter, were low and spreading. Colony color was mediumbrown to dark olive on the surface and dark brown, typically zonate, in reverse. Hyaline aerial mycelia were formed as were abundant pycnidia.
On Czapek's Dox agar colonies grew to 47mmin diameter, were low and spreading. Colony color was drab olive on the surface and darker with marked zonation in reverse. The aerial mycelia were hyaline with brown submeged mycelia. Pycnidia were absent from the colony margin but numerous in other regions of the colony.
Based on morphological and cultural chracteristic the producing culture, SCF-592, was identified as a memberof the genus Phoma. 1^The culture has been deposited in the American Type Culture Collection, Rockville, Maryland as ATCC 74077.
Fermentation
A typical time course for the fermentation is shown in Fig. 1 . The pH decreased from 8 to 4 within 18 hours, accompanied by a similarly rapid drop in the dissolved oxygen concentration. PAFactivity was detected at 48 hours and reached its maximumlevel of activity after 120 hours. At this point the dissolved oxygenconcentration waszero and the packedcell volumewasat its maximum.Thefermentation broth was harvested at this optimal point. Tables 2 and 3 . Assignments of the protons to the relevant carbons were made by HETCOR experiments, and the quaternary carbons were located by DEPTas well as SINEPTexperiments.
As shown in Fig. 2 , the proposed structure and stereochemistry of Sch 47918 were established based on extensive spectroscopic studies as well as a single crystal X-ray diffraction analysis. The detail discussion of structure elucidation and X-ray data is published in a separate paper.12)
The structure of Sch 49026, a relatively non-polar compoundwas deduced as follows. The molecular weight, 272, was established by CI-MS which showed a protonated molecular ion m/z 273 (M + H)+. The molecular formula, C2oH32 (5 unsaturations), was determined by high resolution EI-MS (m/z calcd: 272.2504, found: 272.2499) and carbon NMRdata. UV and IR data (see Table 1 Two additional analogues, Sch 49027 and Sch 49028, were both found to have the same molecular weight 334 on the basis of CI mass spectrometric data that showed a protonated molecular ion m/z 335 (M+H)+. The molecular formula was established as C2oH3004 for both compounds based on high and carbon NMRdata. Similar UV (end absorption) and IR (3430cm" 1, broad, OH) were observed for these two molecules. Although similarities were found in these two compounds, their spectral data were further scrutinized to determine the differences in their structures. The XH and 13C NMRdata of Sch 49028, including COSY, DEPT, HETCORand SINEPT experiments, indicated an olefinic proton signal at 5.42 ppm coupling with an unsaturated carbon at 1 30.4 position-3. The arrangement of the rest of methylene and methyl groups was expected to the similar to Sch 47918. As shown in Fig. 4 , SINEPT experiments suggested the hemi-ketal group in the position between the epoxide and the tetrasubstituted double bond, and the secondary hydroxyl group adjacent to this double bond. The assignment of a five membered ring linked through the ketal-oxygen to methylene carbon was also supported by SINEPT data. The stereochemistry of Sch 49028 was proposed as shown in Fig. 4 based on a direct correlation with Sch 47918 which was determined by X-ray analysis. However, the chiral center at carbon-3 could not be correlated with Sch 479 1 8. The stereochemistry at carbon-3 was determined by NOEexperiment. The absence of an NOEsignal of proton-5 by irradiation of proton-3 suggested that these two protons are trans-oriented, (see Fig. 4 ).
Sch 49027 was found to be a closely related isomer of Sch 49028 with the double bond shifted from the 1,2-position to the 2,3-position on the basis of spectral data analysis. The key evidence in the carbon NMRdata indicated that the carbon-3 signal was shifted to a typical oxygen-attached olefinic range at 148.1(s)ppm, while the methine carbon (C-l) moved to 63.83(d)ppm because of the double bond shift. The chemical shift of the ABquartet which was assigned to methylene protons moved slightly up-field to 4.40ppm, and was further coupled to the adjacent methine proton at 4.18 ppm. All assignments for the remaining part of the molecule were comparable to Sch 49028. Both *H and 13C NMRspectra data strongly suggested the presence of an enol functionality in the molecule. Based on these data, the structure of Sch 49027 is proposed and shown in Fig. 5 .
Biological Properties
The broth filtrate from this culture was initially identified as active in a PAF receptor binding assay using rabbit platelets and [3H]-PAF essentially as described by Hwanget al. 1 3) Subsequently, identification and characterization of the active fractions was assessed using inhibition of PAF-induced humanplatelet aggregation. Table 4 shows the IC50 values for inhibition of PAF-induced platelet aggregation in vitro using freshly prepared human platelet rich plasma. Sch 49028 was the most potent inhibitor having an IC50 value of 1.26/^m. Sch 49026 showed poor solubility in the assay system.
Further evidence that Sch 49028 antagonizes [3H]-PAF binding is that its inhibitory potency decreases with increasing PAF concentration. The IC50 values for Sch 49028 are 1.2fiM at 10nM PAF, 3.0/jm at 25nMPAF and ll.1 /im at 50nMPAF. This result would not be expected if this compound were acting in a non-specific manner to block platelet aggregation. Taken together, these results indicate that Sch 49028 acts by competition with PAFfor receptor binding. The most potent compound, Sch 49028 was further tested for in vivo anti-PAF activity, measured as inhibition of PAF-induced bronchospasm in guinea pigs. This compound was found to be inactive (0% inhibition, n-2) at 5mg/kg, iv. All these compounds were not active against and Gram-positive, and Gram-negative bacteria as well as fungi (Candida sp.) in agar diffusion assays (> 30 ag/disc).
Conclusion
Novel PAF antagonists, Sch 47918, Sch 49026, Sch 49027 and Sch 49028, have been isolated from a Phoma sp. A bicyclic diterpene, verticillol, 14) a plant natural product isolated from the wood of Sciadopitys verticillata Sieb. et Zucc (Taxodiaceae) has a similar macrocyclic ring system. However, it should be noted that the carbon skeleton of the PAF inhibitors described above is different from verticillol because of a rearrangement of the methyl group from carbon-1 to carbon-6 in the molecules. A structurally related compound, phomactin B, was recently reported as a PAFinhibitor.15) These PAFantagonists are new membersof the rare cleomane class of diterpenes, the only previous example being cleomeolide.16'17)
